fludarabine has been researched along with Cancer of Pancreas in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guillen, KP; Harrison, RG; Kurkjian, C; Restuccia, A | 1 |
Barkholt, L; Ericzon, BG; Mattsson, J; Omazic, B; Potácová, Z; Remberger, M; Ringdén, O; Söderdahl, G; Wersäll, P | 1 |
Abe, Y; Arita, Y; Baba, E; Choi, I; Harada, M; Ito, T; Kawabe, K; Miyamoto, T; Nagafuji, K; Nakano, S; Teshima, T | 1 |
Bossow, S; Cattaneo, R; Grossardt, C; Leber, MF; Rieber, EP; Sawall, S; Temme, A; Ungerechts, G; von Kalle, C | 1 |
Hiruma, K; Maeda, Y; Matsumoto, G; Omuro, Y; Sakamaki, H; Sasaki, T; Takahashi, T; Tanaka, Y; Tsuruta, K | 1 |
Aprahamian, M; Deharvengt, S; Hajri, A; Rejiba, S; Wack, S | 1 |
6 other study(ies) available for fludarabine and Cancer of Pancreas
Article | Year |
---|---|
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Topics: Adenine; Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Carbon-Sulfur Lyases; Cell Death; Cell Line, Tumor; Cytosine Deaminase; Docetaxel; Dose-Response Relationship, Drug; Enzymes; Flucytosine; Fluorouracil; Humans; Methanol; Molecular Targeted Therapy; Organoselenium Compounds; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Recombinant Fusion Proteins; Selenomethionine; Taxoids; Tubulin Modulators; Vidarabine | 2015 |
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Myeloablative Agonists; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Male; Middle Aged; Mycophenolic Acid; Pancreatic Neoplasms; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vidarabine; Whole-Body Irradiation | 2009 |
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Chlorocebus aethiops; Combined Modality Therapy; Female; GPI-Linked Proteins; Humans; Male; Measles virus; Mice; Mice, SCID; Neoplasm Proteins; Oncolytic Virotherapy; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Vero Cells; Vidarabine; Xenograft Model Antitumor Assays | 2011 |
Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Topics: Adenocarcinoma; Cyclophosphamide; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Living Donors; Middle Aged; Pancreatic Neoplasms; Siblings; Stem Cell Transplantation; Time Factors; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2003 |
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Electrochemotherapy; Electroporation; Gene Transfer Techniques; Genes, Bacterial; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Neoplasms, Experimental; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Rats; Rats, Inbred Lew; RNA, Messenger; Vidarabine; Xenograft Model Antitumor Assays | 2007 |